Atlas Trials

Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial

Clinical trial NCT01424865 · UNKNOWN

Trial details

NCT number
NCT01424865
Sponsor
NSABP Foundation Inc
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2011-11-01
Primary completion
2015-12-01
Enrollment
1874

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.